Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/15470214

N. Engl. J. Med. 2004 Oct 7 351 15 1513-20

Download in:

View as

Triples

General Info

PMID
15470214